Franklin Resources Inc Athira Pharma, Inc. Transaction History

Franklin Resources Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.74 - $13.43 $5.39 Million - $26.4 Million	-1,967,110 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$8.96 - $13.51 $1.01 Million - $1.53 Million	-112,940 Reduced 5.43%	1,967,110 $26.6 Million
Q4 2021 Feb 11, 2022	SELL	$9.17 - $16.39 $26,317 - $47,039	-2,870 Reduced 0.14%	2,080,050 $27.1 Million
Q3 2021 Nov 12, 2021	BUY	$9.15 - $11.09 $26,260 - $31,828	2,870 Added 0.14%	2,082,920 $19.5 Million
Q2 2021 Aug 13, 2021	BUY	$10.24 - $20.87 $1.99 Million - $4.05 Million	194,149 Added 10.29%	2,080,050 $21.3 Million
Q1 2021 May 13, 2021	BUY	$16.9 - $29.77 $24.9 Million - $43.9 Million	1,474,117 Added 357.98%	1,885,901 $34.7 Million
Q4 2020 Feb 10, 2021	BUY	$16.48 - $34.3 $329 - $686	20 Added 0.0%	411,784 $14.1 Million
Q3 2020 Nov 12, 2020	BUY	$16.02 - $18.46 $6.6 Million - $7.6 Million	411,764 New	411,764 $7.6 Million

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $25M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.